SVRII Family Factors Study

Tracking Information
First Submitted Date	April 19, 2012
First Posted Date	April 20, 2012
Last Update Posted Date	March 1, 2018
Actual Study Start Date	June 2012
Estimated Primary Completion Date	December 2019 (Final data collection date for primary outcome measure)
Current Primary Outcome Measures; (submitted: April 19, 2012)	Parental mental health [ Time Frame: During child's 6th year of life. ]Parental mental health will be assessed with the Patient-Reported Outcomes Measurement Information System (PROMIS) anxiety and depression scales.; Parental quality of life [ Time Frame: During child's 6th year of life. ]Parental quality of life will be assessed with the Satisfaction with Health and Life Scale (SHL) (also referred to as the Perceived Quality of Life Scale).; Family resources [ Time Frame: During child's 6th year of life ]Family resources will be assessed with the Family Inventory of Resources for Management (FIRM.; Family function [ Time Frame: During child's 6th year of life ]Family function will be assessed with the Family Assessment Device (FAD)39 and the Family Management Measure (FaMM.
Original Primary Outcome Measures	Same as current
Change History	Complete list of historical versions of study NCT01582529 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures	Not Provided
Original Secondary Outcome Measures	Not Provided
Current Other Outcome Measures	Not Provided
Original Other Outcome Measures	Not Provided
Descriptive Information
Brief Title	SVRII Family Factors Study
Official Title	The Impact of Family Factors on Developmental and Psychosocial Outcomes in Children With Hypoplastic Left Heart Syndrome (HLHS) at 6 Years of Age - Pediatric Heart Network Single Ventricle Reconstruction Extension (SVR II) Ancillary Study
Brief Summary	The purpose of this study is to learn about the relationship between family factors and developmental and psychosocial outcomes in children with congenital heart disease at 6 years of age. A secondary purpose is to learn more about psychosocial outcomes in children with congenital heart disease and their families over time. About 250 mothers and fathers at 15 medical centers will take part in this study; 35 will be from Children's Hospital of Wisconsin.
Detailed Description	Survival for one of the most complex forms of congenital heart disease (CHD), hypoplastic left heart syndrome (HLHS), has improved dramatically; however, survivors are known to be at risk for both physical and psychosocial morbidity. In congenital heart disease, this psychosocial morbidity has been manifested as delays in cognitive and social development, behavior problems, reduced quality of life, as well as parenting stress, anxiety, and negative impact on the family. We have a relatively limited understanding of the causes of psychosocial morbidity and what factors may impact risk or protection for the child and family. The environment in which a child spends the majority of their time exerts a significant impact on development. For infants and young children this "environment" is most commonly the immediate family. Interactions between illness characteristics and individual family member perceptions and expectations are an important determinant of the family's response to the presence of heart disease in a child. There is a critical gap in our understanding of how family-related factors influence psychosocial outcomes in the CHD population and if there are opportunities to intervene in order to improve outcomes for both children and families. The primary aim of this study is to investigate the relationship between family factors including, parental mental health, parental health-related quality of life (HRQOL), family resources, and family function, and developmental and psychosocial outcomes in children with HLHS at 6 years of age. Secondary aims are to explore for differences in outcomes between different family types and to establish the feasibility of longitudinal investigation of the trajectory of child and family psychosocial function over time in this well-defined cohort of children and parents. Longitudinal assessment of these family factors, in conjunction with neurodevelopmental and psychosocial evaluation of affected children, will provide improved understanding of how and when these factors influence child development. This will help to: Identify children/families at risk for problems,; Elucidate the etiology and progression of psychosocial problems in children with congenital heart disease,; Describe the relationships between child and family outcomes over time, and guide the development of family-focused interventions with a goal of preventing problems. This study will be conducted as an ancillary study to the Single Ventricle Reconstruction Extension Study (SVR II) conducted by the Pediatric Heart Network (PHN). All PHN study sites will be eligible to participate in this study. Participation will be determined by the PHN principal investigator at each site. Parents of children enrolled in SVR II will be eligible to participate in this ancillary study. A multivariable, descriptive design using survey techniques will be utilized. Mothers and fathers of children with HLHS will complete study measures at or near the SVR II 6 year visit. Correlation, regression, and structural equation modeling will be used to test study hypotheses. Results of this study have the potential to better define the family implications of this disease, the risk factors for poor outcomes and ultimately, to guide development of interventions to improve child and family psychosocial outcomes.
Study Type	Observational
Study Design	Observational Model: Cohort; Time Perspective: Prospective
Target Follow-Up Duration	Not Provided
Biospecimen	Not Provided
Sampling Method	Non-Probability Sample
Study Population	Parents of subjects that are enrolled in the "Single Ventricle Reconstructive Extension Study" (SVR) or the SVR II study sponsored by the Pediatric Heart Network.
Condition	Hypoplastic Left Heart Syndrome
Intervention	Not Provided
Study Groups/Cohorts	Not Provided
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Recruitment Information
Recruitment Status	Active, not recruiting
Actual Enrollment; (submitted: February 27, 2018)	187
Original Estimated Enrollment; (submitted: April 19, 2012)	250
Estimated Study Completion Date	December 2019
Estimated Primary Completion Date	December 2019 (Final data collection date for primary outcome measure)
Eligibility Criteria	Inclusion Criteria: Speak English or Spanish; Enrolled in the SVR or SVRII studies Exclusion Criteria: Have not completed the 6 year visit and questionnaires
Sex/Gender	Sexes Eligible for Study: All
Ages	18 Years to 60 Years (Adult)
Accepts Healthy Volunteers	No
Contacts	Contact information is only displayed when the study is recruiting subjects
Listed Location Countries	Canada, United States
Removed Location Countries
Administrative Information
NCT Number	NCT01582529
Other Study ID Numbers	319498; U01HL068270 ( U.S. NIH Grant/Contract )
Has Data Monitoring Committee	Yes
U.S. FDA-regulated Product	Not Provided
IPD Sharing Statement	Not Provided
Responsible Party	Kathleen Mussatto, Children's Hospital and Health System Foundation, Wisconsin
Study Sponsor	Medical College of Wisconsin
Collaborators	Children's Hospital and Health System Foundation, Wisconsin; National Heart, Lung, and Blood Institute (NHLBI); Pediatric Heart Network
Investigators	Principal Investigator: Kathleen A Mussatto, PhD, RN Children's Hospital and Health System Foundation, Wisconsin
PRS Account	Medical College of Wisconsin
Verification Date	February 2018